vs
Side-by-side financial comparison of Canaan Inc. (CAN) and MACROGENICS INC (MGNX). Click either name above to swap in a different company.
MACROGENICS INC is the larger business by last-quarter revenue ($41.2M vs $20.8M, roughly 2.0× Canaan Inc.).
Canaan Inc., doing business as Canaan Creative and known simply as Canaan, is a Singapore-based computer hardware manufacturer. Established in 2013 by N.G. Zhang, Canaan specializes in Blockchain servers and ASIC microprocessors for use in bitcoin mining.
MacroGenics Inc is a clinical-stage biopharmaceutical firm specializing in the research and development of novel immunotherapies for cancer and autoimmune disorders. Its core product pipeline centers on monoclonal antibody-based treatments, with key programs targeting solid tumors and hematological malignancies, supported by partnerships with global pharmaceutical partners.
CAN vs MGNX — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.8M | $41.2M |
| Net Profit | $-3.8M | — |
| Gross Margin | 99.9% | — |
| Operating Margin | -15.9% | -29.3% |
| Net Margin | -18.4% | — |
| Revenue YoY | — | 113.0% |
| Net Profit YoY | — | — |
| EPS (diluted) | $-0.05 | $-0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.8M | $41.2M | ||
| Q3 25 | $13.8M | $72.8M | ||
| Q2 25 | $11.4M | $22.2M | ||
| Q1 25 | — | $13.2M | ||
| Q4 24 | — | $19.4M | ||
| Q3 24 | $10.2M | $110.7M | ||
| Q2 24 | $4.8M | $10.8M | ||
| Q1 24 | — | $9.1M |
| Q4 25 | $-3.8M | — | ||
| Q3 25 | $-1.5M | $16.8M | ||
| Q2 25 | $-11.9M | $-36.3M | ||
| Q1 25 | — | $-41.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-10.4M | $56.3M | ||
| Q2 24 | $-5.4M | $-55.7M | ||
| Q1 24 | — | $-52.2M |
| Q4 25 | 99.9% | — | ||
| Q3 25 | 99.9% | — | ||
| Q2 25 | 99.9% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 98.8% | ||
| Q3 24 | 99.9% | 99.8% | ||
| Q2 24 | 99.8% | 98.4% | ||
| Q1 24 | — | 97.0% |
| Q4 25 | -15.9% | -29.3% | ||
| Q3 25 | -27.0% | 25.6% | ||
| Q2 25 | -45.5% | -165.3% | ||
| Q1 25 | — | -323.1% | ||
| Q4 24 | — | -273.0% | ||
| Q3 24 | -77.2% | 48.9% | ||
| Q2 24 | -193.9% | -538.9% | ||
| Q1 24 | — | -590.4% |
| Q4 25 | -18.4% | — | ||
| Q3 25 | -11.0% | 23.1% | ||
| Q2 25 | -104.4% | -163.0% | ||
| Q1 25 | — | -311.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | -102.7% | 50.9% | ||
| Q2 24 | -112.3% | -515.6% | ||
| Q1 24 | — | -573.3% |
| Q4 25 | $-0.05 | $-0.23 | ||
| Q3 25 | $-0.02 | $0.27 | ||
| Q2 25 | $-0.25 | $-0.57 | ||
| Q1 25 | — | $-0.65 | ||
| Q4 24 | — | $-0.24 | ||
| Q3 24 | — | $0.90 | ||
| Q2 24 | — | $-0.89 | ||
| Q1 24 | — | $-0.84 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $57.2M |
| Total DebtLower is stronger | $6.2M | — |
| Stockholders' EquityBook value | $52.4M | $55.6M |
| Total Assets | $92.5M | $256.8M |
| Debt / EquityLower = less leverage | 0.12× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $57.2M | ||
| Q3 25 | — | $80.1M | ||
| Q2 25 | — | $130.7M | ||
| Q1 25 | — | $145.6M | ||
| Q4 24 | — | $182.8M | ||
| Q3 24 | — | $179.6M | ||
| Q2 24 | — | $83.9M | ||
| Q1 24 | — | $80.4M |
| Q4 25 | $6.2M | — | ||
| Q3 25 | $6.2M | — | ||
| Q2 25 | $6.2M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $52.4M | $55.6M | ||
| Q3 25 | $44.7M | $67.0M | ||
| Q2 25 | $33.8M | $46.6M | ||
| Q1 25 | — | $79.1M | ||
| Q4 24 | — | $116.1M | ||
| Q3 24 | $43.6M | $120.1M | ||
| Q2 24 | $56.8M | $57.8M | ||
| Q1 24 | — | $106.2M |
| Q4 25 | $92.5M | $256.8M | ||
| Q3 25 | $81.7M | $270.8M | ||
| Q2 25 | $78.0M | $245.4M | ||
| Q1 25 | — | $224.6M | ||
| Q4 24 | — | $261.7M | ||
| Q3 24 | $69.3M | $264.5M | ||
| Q2 24 | $73.7M | $201.1M | ||
| Q1 24 | — | $248.3M |
| Q4 25 | 0.12× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $43.0M |
| Free Cash FlowOCF − Capex | — | $42.8M |
| FCF MarginFCF / Revenue | — | 103.8% |
| Capex IntensityCapex / Revenue | — | 0.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-83.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $43.0M | ||
| Q3 25 | — | $-30.2M | ||
| Q2 25 | — | $-47.0M | ||
| Q1 25 | — | $-46.9M | ||
| Q4 24 | — | $-38.4M | ||
| Q3 24 | — | $60.2M | ||
| Q2 24 | — | $-44.5M | ||
| Q1 24 | — | $-45.6M |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $-30.6M | ||
| Q2 25 | — | $-47.7M | ||
| Q1 25 | — | $-47.4M | ||
| Q4 24 | — | $-39.0M | ||
| Q3 24 | — | $59.6M | ||
| Q2 24 | — | $-45.5M | ||
| Q1 24 | — | $-47.1M |
| Q4 25 | — | 103.8% | ||
| Q3 25 | — | -42.0% | ||
| Q2 25 | — | -214.5% | ||
| Q1 25 | — | -359.5% | ||
| Q4 24 | — | -201.7% | ||
| Q3 24 | — | 53.8% | ||
| Q2 24 | — | -421.6% | ||
| Q1 24 | — | -517.4% |
| Q4 25 | — | 0.6% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 3.2% | ||
| Q1 25 | — | 4.0% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 9.6% | ||
| Q1 24 | — | 16.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | -1.79× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.07× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CAN
Segment breakdown not available.
MGNX
| Revenue From Collaborative Agreements | $20.3M | 49% |
| Contract Manufacturing | $11.3M | 27% |
| Other | $9.7M | 23% |
